FR2718450B1
(fr)
*
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
FR2719587B1
(fr)
*
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
FR2727969B1
(fr)
*
|
1994-12-09 |
1997-01-17 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2732023B1
(fr)
*
|
1995-03-22 |
1997-04-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2732684B1
(fr)
*
|
1995-04-06 |
1997-04-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
US5747466A
(en)
*
|
1995-11-08 |
1998-05-05 |
Abbott Laboratories |
3-deoxy-3-descladinose derivatives of erythromycins A and B
|
FR2742757B1
(fr)
*
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2751656B1
(fr)
*
|
1996-07-24 |
1998-10-16 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
ATE296308T1
(de)
*
|
1996-09-04 |
2005-06-15 |
Abbott Lab |
6-o-substituierte ketoliden mit antibakteriellen wirkung
|
UA51730C2
(uk)
*
|
1996-09-04 |
2002-12-16 |
Ебботт Лабораторіз |
6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
|
FR2757168B1
(fr)
*
|
1996-12-12 |
1999-06-11 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2760017B1
(fr)
*
|
1997-02-27 |
1999-04-30 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
|
US5922683A
(en)
*
|
1997-05-29 |
1999-07-13 |
Abbott Laboratories |
Multicyclic erythromycin derivatives
|
CN1259135A
(zh)
*
|
1997-06-11 |
2000-07-05 |
辉瑞产品公司 |
9-肟红霉素衍生物
|
US5780604A
(en)
*
|
1997-09-26 |
1998-07-14 |
Abbott Laboratories |
11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
|
US6034069A
(en)
*
|
1997-09-30 |
2000-03-07 |
Abbott Laboratories |
3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
|
US6046171A
(en)
*
|
1997-10-29 |
2000-04-04 |
Abbott Laboratories |
6,11-bridged erythromycin derivatives
|
AU9649598A
(en)
*
|
1997-10-29 |
1999-05-17 |
Taisho Pharmaceutical Co., Ltd. |
Erythromycin a, 11,12-carbamate derivatives
|
JP2004514643A
(ja)
*
|
1997-10-29 |
2004-05-20 |
大正製薬株式会社 |
エリスロマイシンa誘導体
|
US6124269A
(en)
*
|
1997-10-29 |
2000-09-26 |
Abbott Laboratories |
2-Halo-6-O-substituted ketolide derivatives
|
HRP980189B1
(en)
*
|
1998-04-06 |
2004-04-30 |
Pliva Pharm & Chem Works |
Novel 15-membered lactams ketolides
|
FR2777282B1
(fr)
*
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
JP4573925B2
(ja)
*
|
1998-07-09 |
2010-11-04 |
アベンティス・ファーマ・ソシエテ・アノニム |
新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
|
FR2781484B1
(fr)
*
|
1998-07-21 |
2001-08-10 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
|
AU5299499A
(en)
|
1998-09-22 |
2000-04-10 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
FR2785612A1
(fr)
*
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
KR20010083944A
(ko)
|
1998-11-03 |
2001-09-03 |
실버스타인 아써 에이. |
신규 마크롤라이드 항생물질
|
FR2786188B1
(fr)
*
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
DE69933897T2
(de)
|
1998-12-10 |
2007-03-15 |
Pfizer Products Inc., Groton |
Carbamat- und Carbazatketolid-Antibiotika
|
WO2000044761A2
(en)
|
1999-01-27 |
2000-08-03 |
Pfizer Products Inc. |
Ketolide antibiotics
|
FR2789392B1
(fr)
*
|
1999-02-04 |
2001-10-05 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
US6054435A
(en)
*
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
US6939861B2
(en)
*
|
1999-04-16 |
2005-09-06 |
Kosan Biosciences, Inc. |
Amido macrolides
|
US6514944B2
(en)
|
1999-04-16 |
2003-02-04 |
Kosan Biosciences, Inc. |
Macrolide antiinfective agents
|
US6590083B1
(en)
|
1999-04-16 |
2003-07-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Ketolide antibacterials
|
US6451768B1
(en)
|
1999-04-16 |
2002-09-17 |
Kosan Biosciences, Inc. |
Macrolide antiinfective agents
|
MXPA01010524A
(es)
|
1999-04-16 |
2002-03-14 |
Kosan Biosciences Inc |
Agentes macrolidos anti-infecciosos.
|
HRP990116B1
(en)
*
|
1999-04-20 |
2007-10-31 |
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. |
NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
|
CZ20013733A3
(cs)
*
|
1999-05-24 |
2002-11-13 |
Pfizer Products Inc. |
Deriváty 13-methylerythromycinu
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
EP1146051A3
(en)
*
|
2000-04-10 |
2001-10-31 |
Pfizer Products Inc. |
Erythromycin A derivatives
|
US8063021B2
(en)
*
|
2002-01-17 |
2011-11-22 |
Kosan Biosciences Incorporated |
Ketolide anti-infective compounds
|
US6878691B2
(en)
*
|
2002-05-13 |
2005-04-12 |
Enanta Pharmaceuticals, Inc. |
6-11 bicyclic ketolide derivatives
|
EP1509538A1
(en)
*
|
2002-05-13 |
2005-03-02 |
Enanta Pharmaceuticals, Inc. |
6,11 bicyclic erythromycin derivatives
|
US6841664B2
(en)
|
2002-07-25 |
2005-01-11 |
Enanra Pharmaceuticals, Inc. |
6,11-4-carbon bridged ketolides
|
US7910558B2
(en)
*
|
2002-05-13 |
2011-03-22 |
Enanta Pharmaceuticals, Inc. |
Bridged macrocyclic compounds and processes for the preparation thereof
|
WO2005070918A1
(en)
*
|
2002-05-13 |
2005-08-04 |
Enanta Pharmaceuticals, Inc. |
Process for the preparation of t-11 bicyclic erythromycin derivatives
|
US6753318B1
(en)
|
2002-07-25 |
2004-06-22 |
Enanta Pharmaceuticals, Inc. |
6,11-4-carbon bridged erythromycin derivatives
|
US7064110B2
(en)
*
|
2002-05-13 |
2006-06-20 |
Enanta Pharmaceuticals, Inc. |
6-11 bicycle ketolide derivatives
|
US7273853B2
(en)
*
|
2002-05-13 |
2007-09-25 |
Enanta Pharmaceuticals, Inc. |
6-11 bicyclic ketolide derivatives
|
US7135573B2
(en)
*
|
2002-05-13 |
2006-11-14 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
|
US6764998B1
(en)
|
2003-06-18 |
2004-07-20 |
Enanta Pharmaceuticals, Inc. |
6,11-4C-bicyclic 9a-azalide derivatives
|
AR043050A1
(es)
*
|
2002-09-26 |
2005-07-13 |
Rib X Pharmaceuticals Inc |
Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
|
HRP20020779A2
(en)
|
2002-09-27 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
|
CN1780846A
(zh)
*
|
2003-03-05 |
2006-05-31 |
Rib-X医药品有限公司 |
双官能杂环化合物及其制备和使用方法
|
EP2772254A3
(en)
|
2003-03-10 |
2015-03-11 |
Optimer Pharmaceuticals, Inc. |
Novel Antibacterial Agents
|
US6645941B1
(en)
|
2003-03-26 |
2003-11-11 |
Enanta Pharmaceuticals, Inc. |
6,11-3C-bicyclic 9a-azalide derivatives
|
WO2005007143A2
(en)
*
|
2003-07-14 |
2005-01-27 |
The Board Of Trustees Of The University Of Illinois |
Use of makrolides and ketolides for the treatment of tuberculosis
|
US7276487B2
(en)
*
|
2003-09-23 |
2007-10-02 |
Enanta Pharmaceuticals, Inc. |
9a, 11-3C-bicyclic 9a-azalide derivatives
|
JP2007509980A
(ja)
*
|
2003-10-30 |
2007-04-19 |
リブ−エックス ファーマシューティカルズ,インコーポレイテッド |
二官能性マクロライド複素環式化合物およびそれらの化合物を調製および使用する方法
|
EP1699808A1
(en)
*
|
2003-11-18 |
2006-09-13 |
Rib-X Pharmaceuticals, Inc. |
Bifunctional macrolide heterocyclic compounds and methods of making and using the same
|
WO2005067564A2
(en)
*
|
2004-01-07 |
2005-07-28 |
Enanta Pharmaceuticals, Inc. |
6-11 bicyclic erythromycin derivatives
|
US7265094B2
(en)
*
|
2004-01-09 |
2007-09-04 |
Enanta Pharmaceuticals, Inc. |
9N-substituted 6-11 bicyclic erythromycin derivatives
|
JP5383037B2
(ja)
|
2004-02-27 |
2014-01-08 |
リブ−エックス ファーマシューティカルズ,インコーポレイテッド |
大環状化合物およびそれらを製造し使用する方法
|
CN101120011A
(zh)
*
|
2004-12-21 |
2008-02-06 |
辉瑞产品公司 |
大环内酯
|
US20100035832A1
(en)
*
|
2005-01-12 |
2010-02-11 |
Alpharma Aps |
Macrolides
|
US7384922B2
(en)
*
|
2005-05-04 |
2008-06-10 |
Enanta Pharmaceuticals, Inc. |
6-11 bridged oxime erythromycin derivatives
|
WO2006129257A2
(en)
*
|
2005-05-30 |
2006-12-07 |
Ranbaxy Laboratories Limited |
Ketolide derivatives as antibacterial agents
|
EP1779849A1
(en)
*
|
2005-10-28 |
2007-05-02 |
Nikem Research S.R.L. |
V-ATPase inhibitors for the treatment of septic shock
|
CN100424089C
(zh)
*
|
2006-01-18 |
2008-10-08 |
中国药科大学 |
一种制备大环内酯类半合成抗生素泰利霉素的方法
|
US8273720B2
(en)
*
|
2007-09-17 |
2012-09-25 |
Enanta Pharmaceuticals, Inc. |
6,11-bicyclolides: bridged biaryl macrolide derivatives
|
US8354383B2
(en)
*
|
2007-09-17 |
2013-01-15 |
Enanta Pharmaceuticals, Inc. |
6,11-bridged biaryl macrolides
|
EP2203435B1
(en)
*
|
2007-09-17 |
2018-07-18 |
Enanta Pharmaceuticals, Inc. |
6, 11-bridged biaryl macrolides
|
CN101917850B
(zh)
*
|
2007-10-25 |
2016-01-13 |
森普拉制药公司 |
大环内酯类抗菌剂的制备方法
|
EP2220104A1
(en)
*
|
2007-10-25 |
2010-08-25 |
Sandoz AG |
Process for the production of telithromycin
|
TW200946109A
(en)
*
|
2008-05-09 |
2009-11-16 |
Enanta Pharm Inc |
Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
|
CN102245195B
(zh)
|
2008-10-24 |
2016-01-13 |
森普拉制药公司 |
使用含三唑的大环内酯的生物防御
|
US9937194B1
(en)
|
2009-06-12 |
2018-04-10 |
Cempra Pharmaceuticals, Inc. |
Compounds and methods for treating inflammatory diseases
|
JP5914335B2
(ja)
|
2009-09-10 |
2016-05-11 |
センプラ ファーマシューティカルズ,インコーポレイテッド |
マラリア、結核、及びmac病の治療方法
|
CN108570083A
(zh)
|
2010-03-22 |
2018-09-25 |
森普拉制药公司 |
大环内脂的结晶形式及其用途
|
CN102917708B
(zh)
|
2010-05-20 |
2015-11-25 |
森普拉制药公司 |
制备大环内酯和酮内酯及其中间体的方法
|
KR20130120458A
(ko)
*
|
2010-09-10 |
2013-11-04 |
셈프라 파마슈티컬스, 인크. |
질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
|
DE102010055322A1
(de)
*
|
2010-12-21 |
2012-06-21 |
Christian-Albrechts-Universität Zu Kiel |
Antibakteriell und antimykotisch wirkende Substanzen
|
AU2013239696C1
(en)
|
2012-03-27 |
2018-11-29 |
Cempra Pharmaceuticals, Inc. |
Parenteral formulations for administering macrolide antibiotics
|
EP2968801B1
(en)
|
2013-03-14 |
2018-09-26 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
EP2968384A4
(en)
|
2013-03-15 |
2017-02-15 |
Cempra Pharmaceuticals, Inc. |
Convergent processes for preparing macrolide antibacterial agents
|